Seattle biotech company Phase Genomics announced Wednesday that it received two National Institutes of Health (NIH) grants totaling $3.9 million.… Read More
An international research team led by University of Washington scientists has identified two kinds of “ultrapotent human antibodies” that could… Read More
Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions.… Read More
Providence’s Digital Innovation Group is adding two Seattle entrepreneurs and former colleagues to lead its newest incubated health tech startup,… Read More
Seattle startup Optimize.health raised $15.6 million to help meet demand for its remote patient monitoring technology as investor interest in… Read More